MedAlliance Enrolls First US Patient into its Third FDA IDE Study: SFA SELUTION4SFA

This study evaluates SELUTION SLR in the treatment of occlusive disease of the superficial femoral artery (SFA) and proximal popliteal artery (PPA) and has been designed to support FDA approval 

Related Keywords

Bradenton ,Florida ,United States ,Manatee Memorial Hospital ,S Jay Mathews ,Arthur Lee ,Vascular Institute ,Cell Adherent Technology ,Investigational Device Exemption ,Co Principal Investigator ,Middle East ,